Cargando…
Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease
This is a unique report of two cases of patients with end-stage renal disease on hemodialysis, receiving ipilimumab for treatment of metastatic melanoma, as there is a paucity of safety and efficacy data in this patient subgroup.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304535/ https://www.ncbi.nlm.nih.gov/pubmed/25632239 http://dx.doi.org/10.2147/CMAR.S73389 |